KaiLi Medical: Plans to repurchase company shares with 100 million to 200 million yuan

2026-03-29 19:06:21

The opening of a medical announcement stating that the company intends to use its own funds or self-raised funds to repurchase shares through centralized competitive bidding. The repurchase amount will be no less than RMB 100 million and no more than RMB 200 million, with a maximum price of RMB 40.32 per share. The estimated number of shares to be repurchased is between 2.4802 million and 4.9603 million shares, accounting for 0.57% to 1.15% of the company’s total share capital.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes